| CTRI Number |
CTRI/2020/11/029443 [Registered on: 27/11/2020] Trial Registered Prospectively |
| Last Modified On: |
12/03/2021 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [Complex Healthcare Intervention] |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
AIIMS ICU Rehabilitation Project |
Scientific Title of Study
Modification(s)
|
Home-Based Rehabilitation for chronically ill ICU patients- AIR project |
|
Secondary IDs if Any
|
| Secondary ID |
Registry |
| NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)
|
| Name |
Swagata Tripathy |
| Address |
Room 406, Academic Block,
AIIMS, Bhubaneswar. Sijua, Patrapada
Khordha ORISSA 751019 India |
| Phone |
08763400534 |
| Fax |
|
| Email |
tripathyswagata@gmail.com |
|
Details Contact Person Scientific Query
Modification(s)
|
| Name |
Swagata Tripathy |
| Address |
Room 406, Academic Block,
AIIMS, Bhubaneswar. Sijua, Patrapada
Khordha ORISSA 751019 India |
| Phone |
08763400534 |
| Fax |
|
| Email |
tripathyswagata@gmail.com |
|
Details Contact Person Public Query
Modification(s)
|
| Name |
Swagata Tripathy |
| Address |
Room 406, Academic Block,
AIIMS, Bhubaneswar. Sijua, Patrapada
Khordha ORISSA 751019 India |
| Phone |
08763400534 |
| Fax |
|
| Email |
tripathyswagata@gmail.com |
|
Source of Monetary or Material Support
Modification(s)
|
| National Health Mission,
Annex Building, SIHFW, Bira Maharana Ln, Nilakantha Nagar, Nayapalli, Bhubaneswar, Odisha 751012 |
|
Primary Sponsor
Modification(s)
|
| Name |
Swagata Tripathy |
| Address |
Room 406, Academic Block
Sijua, Patrapada,
AIIMS Bhubaneswar |
| Type of Sponsor |
Other [] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
Sites of Study
Modification(s)
|
| No of Sites = 1 |
| Contact Person |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Swagata Tripathy |
AIIMS Bhubaneswar |
Room 406, Academic Block,Sijua, Patrapada
Khordha |
08763400534
tripathyswagata@gmal.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| AIIMS Bhubaneswar |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
Illness, unspecified |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Development, Piloting, Evaluation, and Implementation of a Complex Intervention to support iHome Based Rehabilitation Project for Chronically Ill ICU patients |
The complex intervention is proposed to have 3 limbs- Training & Nutrition/ Mobile app/ Equipment bank |
| Comparator Agent |
This will be in the phase of final evaluation of the complex intervention, after field testing. |
The group of patients who refuse the intervention or adopt certain limited limbs of the intervention will form the comparator arm |
|
|
Inclusion Criteria
|
| Age From |
16.00 Year(s) |
| Age To |
99.99 Year(s) |
| Gender |
Both |
| Details |
Chronically ill, tracheostomised ICU patients
Family or caregiver motivated to accept the complex healthcare intervention |
|
| ExclusionCriteria |
| Details |
Hemodynamically unstable, Braindead or family not motivated to accept the intervention |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
Primary Outcome
Modification(s)
|
| Outcome |
TimePoints |
| Feasibility and acceptibility of designing, testing and implementing a complex healthcare intevention for the chronically ill, ICU patient |
Daily in-hospital and weekly after rehabilitation for first 1 month and second weekly or as needed thereafter |
|
Secondary Outcome
Modification(s)
|
| Outcome |
TimePoints |
| Field testing and evaluation of the complex intervention |
weekly. Post development stage as per MRC guidelines for development of complex healthcare intervention |
|
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
01/12/2020 |
| Date of First Enrollment (Global) |
No Date Specified |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
NIL |
|
Brief Summary
|
Research protocol for Development, Piloting, Evaluation, and Implementation of a Complex Intervention to support Home Based Rehabilitation Project for Chronically Ill ICU patients- AIIMS ICU Rehabilitation Project - AIR. Overall aims of the research program
1. To understand from different perspectives, the range of supportive care needs for people with chronic critical illness requiring tracheostomy (Tracheostomised ICU Patient for rehab- TIPr) and the impact that these impairments have on outcomes such as quality of life and caregiver burden. 2. To design, pilot, field test, and evaluate a complex rehabilitative support care intervention - theoretically informed, test ready for a follow-up with a full scale definitive randomized controlled trial (RCT), if the field test of the development program appears favorable. 3. To evaluate the complex intervention with a full-scale RCT
Primary specific objectives Stage 1: Mapping the gaps - To define the gaps in knowledge, understanding, availability, and hurdles in the support needs for chronic tracheostomized patients (TIPr) – by using inputs from the stakeholders- the patient, family stakeholders, and evidence from the literature. Stage 2: Developing a prototype complex intervention with preconceived arms (project protocol) as discussed with the funding agency, but refine the arms by examining the particular needs of the populace by utilizing a mixed-methods technique. Stage 3: Refining the intervention further into a draft intervention prepared for field testing; Stage 4: Field trial of the draft intervention The acceptability and feasibility of the prototype intervention will be tested. The most significant/ useful outcome measures that might be useful in the full trial –which will be taken as secondary specific objectives will be studied, assessed, and ascertained.
|